Get started
Author

Dominique Luyts

Observed institution: GlaxoSmithKline (Belgium)
ORCID: 0000-0001-8195-1526
Observed ORCID: 0000-0001-8195-1526
OpenAlex ID: A5069044329
Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 Pandemic
2023 · Young J. Juhn, Chung-Il Wi, et al. · JAMA Network Open · 48
PDF
Self-reported sexual debut and behavior in young adults aged 18–24 years in seven European countries: Implications for HPV vaccination programs☆
2009 · Anne Crochard, Dominique Luyts, et al. · Gynecologic Oncology · 35
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study
2023 · Sílvia Narejos Pérez, Josep María Ramón Torrell, et al. · Open Forum Infectious Diseases · 18
PDF
Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study
2019 · Mauro Sancovski, Narcisa Mesaros, et al. · Human Vaccines & Immunotherapeutics · 15
PDF
Postmarketing safety surveillance for GSK’s AS01 E -adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study
2026 · Sruthi Adimadhyam, Dominique Luyts, et al. · BMJ Open · 1
Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis
2026 · Jennifer H Ku, Lei Qian, et al. · Open Forum Infectious Diseases
Works count: 6
Citation count: 117
H-index: 4
I10-index: 4
Year
Topic
Type